These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16688961)

  • 1. [A case of follicular lymphoma of the duodenum treated with the combined therapy of anti-CD20 antibody and chemotherapy].
    Isogai K; Yamamoto E; Yamaoka S; Tarasawa I; Murakami R; Morimoto I; Obata T; Mori M; Endo T; Imai K
    Nihon Shokakibyo Gakkai Zasshi; 2006 Mar; 103(3):301-9. PubMed ID: 16688961
    [No Abstract]   [Full Text] [Related]  

  • 2. Hematology: The case against rituximab maintenance.
    Cheson BD
    Nat Rev Clin Oncol; 2009 Nov; 6(11):622-4. PubMed ID: 19861992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody therapy in hematology and oncology - part 1].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2008 Dec; 103(12):843-59. PubMed ID: 19099214
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of rituximab in patients with follicular lymphoma.
    Marcus R
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):38-49. PubMed ID: 17305253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
    Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
    Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.
    Falorio S; Angrilli F; Fioritoni G
    Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763
    [No Abstract]   [Full Text] [Related]  

  • 7. Counterpoint: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?
    Barr PM
    Oncology (Williston Park); 2018 Aug; 32(8):404, 407-9. PubMed ID: 30153320
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematology: Follicular lymphoma: maintenance therapy is (often) indicated.
    Seymour JF
    Nat Rev Clin Oncol; 2009 Nov; 6(11):624-6. PubMed ID: 19861993
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary duodenal follicular lymphoma successfully treated with rituximab.
    Aguiar-Bujanda D; Quiñones-Morales I; Camacho-Galán R; Llorca-Martínez I; Rivero-Vera JC; Bohn-Sarmiento U; Aguiar-Morales J
    Clin Transl Oncol; 2007 Jul; 9(7):471-2. PubMed ID: 17652063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
    Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
    Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.
    Dakhil S; Hermann R; Schreeder MT; Gregory SA; Monte M; Windsor KS; Hurst D; Chai A; Brewster M; Richards P
    Leuk Lymphoma; 2014 Oct; 55(10):2335-40. PubMed ID: 24471908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstructive jaundice caused by primary duodenal lymphoma. Case report and review of the literature.
    Peter U; Honegger H; Koelz HR
    Digestion; 2007; 75(2-3):124-5. PubMed ID: 17630473
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effectiveness of treatments for newly diagnosed follicular non-Hodgkin lymphoma.
    Messori A; Fadda V; Maratea D; Trippoli S
    Leuk Lymphoma; 2015; 56(9):2728-30. PubMed ID: 25651429
    [No Abstract]   [Full Text] [Related]  

  • 14. Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
    Watanabe R; Tomita N; Kishimoto K; Koyama S; Ogusa E; Ishii Y; Miyashita K; Matsuura S; Fujisawa S; Hattori Y; Takasaki H; Fujita A; Ohshima R; Kuwabara H; Hashimoto C; Fujimaki K; Sakai R; Ishigatsubo Y
    Leuk Res; 2013 Oct; 37(10):1208-12. PubMed ID: 23927994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenalidomide and R-CHOP in follicular lymphoma: where do we go from here?
    Gordon LI
    Lancet Haematol; 2018 Sep; 5(9):e381-e382. PubMed ID: 30172340
    [No Abstract]   [Full Text] [Related]  

  • 16. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
    Provencio M; Cruz Mora MÁ; Gómez-Codina J; Quero Blanco C; Llanos M; García-Arroyo FR; de la Cruz L; Gumá Padró J; Delgado Pérez JR; Sánchez A; Alvarez Cabellos R; Rueda A;
    Leuk Lymphoma; 2014 Jan; 55(1):51-5. PubMed ID: 23573825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningeal relapse by follicular lymphoma as a single mass.
    Moreno García V; Redondo A; Fernández Zubillaga A; González-Barón M
    Clin Transl Oncol; 2008 Mar; 10(3):180-1. PubMed ID: 18321822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does monocyte count have prognostic significance in cancer?
    Tadmor T
    Leuk Res; 2013 Oct; 37(10):1193-4. PubMed ID: 23953915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synchronous cervical intraepithelial neoplasia and cervical follicular non-Hodgkin lymphoma: report of a case].
    Zhu H; Xie JL; Yu R; Gong LP; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):841-2. PubMed ID: 20193463
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy.
    Griffiths R; Gleeson M; Reyes C; Knopf K; Danese M
    Am J Hematol; 2010 Dec; 85(12):963-7. PubMed ID: 20981680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.